Publications by authors named "Tim Buss"

Article Synopsis
  • Modern medicine aims to enhance treatment effectiveness while minimizing side effects, with nanoparticles (NPs) offering promising potential for targeted drug delivery and imaging.
  • However, the small size of NPs often leads to quick removal from the bloodstream and limited effectiveness due to challenges in crossing important cell barriers.
  • This research demonstrates a method to exploit endothelial caveolae in the lungs to improve NP delivery, achieving higher lung concentrations than in the bloodstream, which could enhance both diagnostics and therapies in future medical applications.
View Article and Find Full Text PDF

The long-sought-after "magic bullet" in systemic therapy remains unrealized for disease targets existing inside most tissues, theoretically because vascular endothelium impedes passive tissue entry and full target engagement. We engineered the first "dual precision" bispecific antibody with one arm pair to precisely bind to lung endothelium and drive active delivery and the other to precisely block TGF-β effector function inside lung tissue. Targeting caveolae for transendothelial pumping proved essential for delivering most of the injected intravenous dose precisely into lungs within one hour and for enhancing therapeutic potency by >1000-fold in a rat pneumonitis model.

View Article and Find Full Text PDF

Molecular medicine can benefit greatly from antibodies that deliver therapeutic and imaging agents to select organs and diseased tissues. Yet the development of complex and defined composite nanostructures remains a challenge that requires both designed stoichiometric assembly and superior in vivo testing ability. Here, we generate nanostructures called nanostreptabodies by controlled sequential assembly of biotin-engineered antibody fragments on a streptavidin scaffold with a defined capacity for additional biotinylated payloads such as other antibodies to create bispecific antibodies as well as organic and non-organic moieties.

View Article and Find Full Text PDF

Mapping protein expression of endothelial cells (EC) in vivo is fundamental to understanding cellular function and may yield new tissue-selective targets. We have developed a monoclonal antibody, MAb J120, to a protein expressed primarily in rat lung and heart endothelium. The antigen was identified as CD34, a marker of hematopoietic stem cells and global marker of endothelial cells in human and mouse tissues.

View Article and Find Full Text PDF